Intracranial Arteriosclerosis: Clinical Trials

1 trial for Intracranial Arteriosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow Intracranial Arteriosclerosis: new trials by email Literature Review of Intracranial Arteriosclerosis trials Research Report on Intracranial Arteriosclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
Alirocumab, Placebo - Stroke, Intracranial Atherosclerosis
Early Phase 1TerminatedUniversity of Utah202018-10-302020-04-21

Narrower conditions

Stroke (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Intracranial Arterial Diseases (1)  ·  Nervous System Diseases (1)  ·  Vascular Diseases (1)

Interventions

alirocumab (1)

Sponsors

University of Utah (1)

Countries

United States (1)

Top investigators

Adam de Havenon, MD (1)  ·  Scott McNally, MD, PhD (1)